InfuSystem Holdings (INFU) Capital Expenditures (2010 - 2026)
InfuSystem Holdings (INFU) posted Capital Expenditures of $157000.0 for Q1 2026, down 94.11% on a QoQ basis from $2.7 million in Q4 2025, and up 121.54% year-over-year from $70868.7 in Q1 2025.
InfuSystem Holdings (INFU) Capital Expenditures (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Capital Expenditures history runs 17 years deep, the most recent figure standing at $157000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 121.54% year-over-year to $157000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 272.59% YoY) and the FY2025 annual result came in at $3.1 million, up 258.42% from the prior year.
- Capital Expenditures was $157000.0 for Q1 2026 at InfuSystem Holdings, down from $2.7 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $2.7 million in Q4 2025 and bottomed at -$2.1 million in Q4 2023.
- A 5-year average of $202882.4 and a median of $157000.0 in 2026 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 904.55% in 2023, while the deepest fall reached 254.4% in 2023.
- InfuSystem Holdings' Capital Expenditures stood at $1.3 million in 2022, then sank by 254.4% to -$2.1 million in 2023, then surged by 60.29% to -$816000.0 in 2024, then surged by 426.84% to $2.7 million in 2025, then plunged by 94.11% to $157000.0 in 2026.
- Business Quant data shows INFU's Capital Expenditures at $157000.0 in Q1 2026, $2.7 million in Q4 2025, and $79000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 157,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157,000.00 |
| Mar 31, 2026 | 157,000.00 |
| Dec 31, 2025 | 2.67 Mn |
| Dec 31, 2025 | 2.67 Mn |
| Sep 30, 2025 | 79,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | -729,000.00 |
| Mar 31, 2025 | -729,000.00 |
| Dec 31, 2024 | -816,000.00 |
| Dec 31, 2024 | -816,000.00 |
| Sep 30, 2024 | -1.66 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | 895,000.00 |
| Jun 30, 2024 | 895,000.00 |
| Mar 31, 2024 | -376,000.00 |
| Mar 31, 2024 | -376,000.00 |
| Dec 31, 2023 | -2.06 Mn |
| Dec 31, 2023 | -2.06 Mn |